Navigation Links
Tengion Announces Significant Advances in Neo-Urinary Conduit™ and Neo-Kidney Augment™ Programs
Date:3/26/2012

urrently in development that aims to avoid the use of bowel tissue.

About the Neo-Kidney Augment
The Neo-Kidney Augment is intended to prevent or delay the need for dialysis or kidney transplant by catalyzing the regeneration of functional kidney tissue in patients with advanced chronic kidney disease (CKD). This increase in functional kidney mass could thereby delay or prevent the need for dialysis or kidney transplant in patients with end stage renal disease (ESRD). According to the United States Renal Data System, more than $27 billion in Medicare costs each year are attributable to patients with ESRD and ESRD is associated with an approximate 20% mortality rate per year, with the average life expectancy of a patient initiating dialysis of approximately four years. Tengion scientists have published and presented positive data on the effect of the Company's Neo-Kidney Augment in four different preclinical models of CKD. Two of these preclinical models have been conducted for a sufficiently long period of time to demonstrate durability and an impact on survival.

About Tengion
Tengion, a clinical-stage regenerative medicine company, is focused on discovering, developing, manufacturing and commercializing a range of neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ.  Using its Organ Regeneration Platform, the Company creates neo-organs using a patient's own cells, or autologous cells.  Tengion's proprietary product candidates harness the intrinsic regenerative pathways of the body to regenerate a range of native-like organs and tissues.  The Company's product candidates are intended to delay or eliminate the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.  An initial clinical trial
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tengion Appoints John L. Miclot President and Chief Executive Officer
2. Tengion to Present at Piper Jaffray 23rd Annual Health Care Conference
3. Tengion Provides Business Update and Reports Third Quarter 2011 Financial Results
4. Tengion Appoints Scott Flora to Board of Directors
5. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
6. Tengion Provides Update on Neo-Urinary Conduit Clinical Trial
7. Tengion Announces FDA Orphan-Drug Designation for Neo-Urinary Conduit
8. Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
9. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
10. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
11. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Air Products (NYSE: ... of medical oxygen is vital to any healthcare facility. ... that not only improve the efficiency of its oxygen ... will highlight these systems—including systems for emergency oxygen ... loss—from August 4-5 at the 51 st ...
(Date:7/28/2014)... July 28, 2014  VigeneTech, Inc, in collaboration ... LEGENDplex™ Data Analysis Software, an OEM software solution ...  BioLegend develops and offers varieties of bead-based multi-analyte ... the support of VigeneTech,s data analysis software, FCS ... and easily reported LEGENDplex™ software ...
(Date:7/28/2014)...  UBM Medica US announces that Diagnostic ... imaging professionals, explored the complex situation regarding measuring ... The shift from fee-for-service has left radiology at ... is determined in the new payment model . ... field, who recognized the complexity of the radiologist,s value: ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Diagnostic Imaging Delves into Measuring the Radiologist's Value 2
... drug candidate may help patients with Systemic Lupus Erythematosus ... ... SAN FRANCISCO, Calif., April 29 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ... lupus prone mice and,significantly improved their survival as reported in a ...
... Terumo Heart, Inc. announced,a presentation at ... presentation,entitled "Long Term Circulatory Support with the ... Patients Eligible for,Transplantation: European Experience" was delivered ... for Terumo Heart, Inc., (Photo: ...
Cached Medicine Technology:Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 2Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 3Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 4Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants 2
(Date:7/28/2014)... are on the cusp of revolutionizing health care, armed ... from cardiac measurements to sonograms. , While tremendous potential ... costs, several health law experts say in a just-published ... that more oversight is needed by the U.S. Food ... safety. Out of some 100,000 mHealth apps on the ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According ... Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition ... ALD), Product (Power, Opto-electronic), Application, and Geography-2013-2020", published ... at a CAGR of 12.63% from 2014 to ... Browse 121 market data tables and 88 figures ...
(Date:7/28/2014)... July 28, 2014 According to a ... Solution Software Market- Global Industry Analysis, Size, Share, Growth, ... device market was valued at USD 3,005 million in ... of 13.8% from 2014 to 2020, to reach an ... Globally, the e-clinical solution software market is witnessing significant ...
(Date:7/28/2014)... in Taiwan has developed a new optical technology that ... diabetes sooner, when it is more easily treated. If ... it may pave the way for the early detection ... autonomic neuropathy, which is common among people with both ... affects the autonomic nerves controlling vital organs like the ...
(Date:7/28/2014)... Axiom EPM , a leading ... performance management software for enterprises, today announced that it ... that surpassed its record Q1 results, and adding more ... this growth to increased demand for its comprehensive suite ... addition of incremental solutions for existing customers. New clients ...
Breaking Medicine News(10 mins):Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Axiom EPM Announces Record Second Quarter of 2014 2
... seems to be reaching epidemic proportions, forcing changes in ... are now revamping their fleet of ambulances to cope ... ,Super-sized vehicles have been introduced and new air ... ambulances will now be equipped with heavy-duty stretchers, capable ...
... has approved four new drugs manufactured by the Macleods of ... of the four would be used against some strains of ... these four medicines will reinforce efforts to scale up access ... a statement. ,The medicines are the first TB ...
... While it is well known that genetics and family history ... lifestyle choices which include diet//, exercise and environment, do play ... session of the American College of Cardiology looked at many ... person’s chances of being diagnosed with heart disease. ...
... claim that they can efficiently seek out and kill ... very similar to the Nature's way of distinguishing one ... tumor targeting strategy, presented today (March 25) at the ... harnesses one of the body's natural antibodies and immune ...
... has sought for more organ donations so as to meet ... According to him there is a big gap between the ... ,Statistics reveal that 1.5 million patients need organ transplants each ... In China organs are donated by people after signing voluntary ...
... all mental health units in England and Wales revealed ... This is much against the government’s claim that this ... ,The healthcare commission reports that 55% of in-patients are ... opposite sex. This practice has resulted in an increase ...
Cached Medicine News:Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:Role of Lifestyle Choices in Heart Risks 2Health News:Role of Lifestyle Choices in Heart Risks 3Health News:Tumors Targeted Naturally 2Health News:Tumors Targeted Naturally 3
... innovative Mesh Cathode of the OsteoGen™-M ... and a scaffolding effect designed to ... fracture ends in the management of ... product particularly appropriate for high-risk patients ...
... implanted bone growth stimulator is a useful adjunct ... already planned or when patient compliance may be ... implanted, patients are assured of therapeutic treatment directly ... for up to 6 months. , ,The OsteoGen ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Interference Screw has unique, double-helix ... while limiting veering and divergence. ... abrasion where it is most ... thread enables screws to be ...
Medicine Products: